Project 3: Adolescent Nicotine
Project 3: Adolescent Nicotine
批准号:
9151765
负责人:
M. Imad Damaj
金额:
$17.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2021-04-30
关键词:
AcuteAddressAdolescenceAdolescentAdultAffectAgeAlcoholsAnimalsArchitectureBehaviorBehavioralBehavioral ParadigmBiologicalCandidate Disease GeneChromosome MappingCircadian RhythmsCocaineCorpus striatum structureDataDopamineDoseDrug AddictionDrug abuseDrug usageElectronic cigaretteExhibitsExposure toGene ExpressionGenesGeneticGenetic VariationGenotypeGoalsHealthHumanImpulsivityInbreedingIndividualIndividual DifferencesInterventionIntravenousLaboratoriesLifeLinkMapsMeasurementMeasuresMediatingMethodsMolecular GeneticsMusNicotinePharmaceutical PreparationsPhenotypePopulationPopulation GeneticsPredispositionQuantitative Trait LociRewardsRiskRisk FactorsRodentSalineSelf AdministrationSeveritiesSignal TransductionSubstance Use DisorderSushi DomainSystemTechnologyTestingTimeTobaccoTobacco useaddictionadolescent drug usebasebehavioral responsebiobankcigarette smokingcohortdrug of abuseearly adolescencefollow-upgenetic analysisgenome editinghigh riskillicit drug usemouse modelneurobiological mechanismneurogeneticsnovelpreferenceresponsetraitvalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY PROJECT 3 – ADOLESCENT NICOTINE
Nicotine is one of the most commonly used drugs among adolescents. Several studies link tobacco and
nicotine use in human adolescence and subsequent problems in adulthood, including later tobacco, alcohol,
cocaine and other illicit drug use. Individuals who smoke cigarettes before the age of 15 are estimated to be
eighty times more likely to use illegal drugs such as cocaine than those who do not. In addition, studies in
animals have shown that adolescent nicotine exposure affects nicotine and cocaine reward and sensitivity in
rodents; we have shown that repeated exposure to low doses of nicotine in adolescence clearly induces age-
specific enhancement of the rewarding effects of nicotine and other drugs of abuse that persisted long after the
termination of nicotine exposure. However, the molecular and genetic mechanisms underlining nicotine-
induced enhancements to the reward effects are still unclear. This project will identify risk associated genes
and gene networks using highly diverse mouse genetic populations. We will use inbred Collaborative Cross
(CC)/ Diversity Outcross (DO) founder and CC strains to measure nicotine reward using the conditioned place
preference (CPP) test after exposure to nicotine in early adolescence. These data will be used to conduct
genetic correlations across behaviors including impulsivity, cocaine self-administration (IVSA), acute and
sensitized cocaine induced locomotor activation and circadian rhythms to determine common genetic
architecture shared among traits. We will also study changes in striatal dopamine (DA) signaling in CC strains
that exhibit extreme behavioral responses to nicotine. Secondly, we will correlate nicotine CPP behaviors with
gene expression changes in the striatum of CC mice to further identify potential candidate genes, gene
networks and biological mechanisms that may mediate the effects of adolescent nicotine exposure. Finally, we
will map nicotine reward in the CPP test in a large DO cohort after exposure to nicotine during early
adolescence. Genotype data will be used to reveal QTLs specific to nicotine in adolescence as well as identify
common QTLs shared between impulsivity, cocaine self-administration, cocaine sensitization and circadian
rhythms phenotypes generated by the various projects and cores within the Center for Systems Neurogenetics
of Addiction. Genetic mapping data along with expression studies will be used to identify candidate genes for
validation studies in novel mouse models made through genome editing technologies. If successful, this
application promises to have a significant positive impact on human health through the identification of
genetically high-risk individuals who would benefit from proactive interventions following nicotine exposure in
adolescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
-
批准号:10668781
-
项目类别:
-
资助金额:$61.39万
-
财政年份:2023
-
负责人:M. Imad Damaj
-
依托单位:
Initial Development of AEG-1 inactivation as a possible strategy for pain treatment
-
批准号:10454012
-
项目类别:
-
资助金额:$117.97万
-
财政年份:2022
-
负责人:M. Imad Damaj
-
依托单位:
VCU Health Education Opportunities for Teachers (HERO-T)
-
批准号:10399423
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2021
-
负责人:M. Imad Damaj
-
依托单位:
VCU Health Education Opportunities for Teachers (HERO-T)
-
批准号:10596118
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2021
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:9758078
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:10380160
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:10598056
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
-
批准号:10198858
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
Genetic basis of nicotine withdrawal in a reduced complexity cross
-
批准号:10401810
-
项目类别:
-
资助金额:$55.42万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
Genetic basis of nicotine withdrawal in a reduced complexity cross
-
批准号:9920699
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
-
批准号:9750651
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
-
批准号:9892956
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2016
-
负责人:M. Imad Damaj
-
依托单位:
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
-
批准号:9101341
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2016
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8889863
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2014
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8320538
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8998014
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8598866
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Evaluation of Buproprion in Nicotine Dependence Model
-
批准号:7620453
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2008
-
负责人:M. Imad Damaj
-
依托单位:
Evaluation of Buproprion in Nicotine Dependence Model
-
批准号:7514125
-
项目类别:
-
资助金额:$14.33万
-
财政年份:2007
-
负责人:M. Imad Damaj
-
依托单位:
Role of calcium-dependent mechanisms in nicotine's tolerance and effects
-
批准号:7667762
-
项目类别:
-
资助金额:$21.27万
-
财政年份:2001
-
负责人:M. Imad Damaj
-
依托单位:
海外基金